• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries
IATI News & Events Daily Industry News Israeli Startups Set Record for Exits in 2014

Israeli Startups Set Record for Exits in 2014

Jan. 4, 2015

Israeli high-tech and biotech startups witnessed a record year of acquisitions and initial public offerings (IPOs), according to end-of-year reports by accounting firm PricewaterhouseCoopers (PwC) and Ethosia Human Resources. The reports show that 52 Israeli startups exited to the tune of some $15 billion this year, while 18 IPOs racked up $9.8 billion.

Kontera ($150 million), Cyvera ($200 million), SuperDerivatives ($350 million), Simbionix ($120 million), Green Smoke ($110 million) and Wilocity ($300 million) were among the top blue-and-white acquisitions of 2014.

Jonathan Medved, CEO of OurCrowd equity crowdfunding, tells ISRAEL21c that the pace of investment in Israel is surprisingly swift. “2013 was already a good year by Israeli standards. The fact that 2014 is up 30 to 40 percent is shocking,” he says.

But whereas years past were all about Israeli companies scoring big exits, 2014 showed a transition to successful IPOs and globalization.

“Companies that in the past were able to sell themselves and earn big returns for investors are going to the end with a share offering and building big companies,” Rubi Suliman, head of PriceWaterhouseCoopers Israel’s high-tech practice, told Ha’aretz.

This year’s IPO crop was led by collision-avoidance technology company Mobileye ($890 million), which achieved the largest-ever IPO of an Israeli company.

Altogether, 18 Israeli tech companies raised $9.8 billion in IPOs this past year, according to figures in the PwC report. This represents a huge jump on the $1.2 billion from 2013.

Cybersecurity company CyberArk Software, digital advertising group Crossrider and robotic exoskeleton maker ReWalk also recorded top IPO performances this year.

For the full feature story on Israel21c click here

| Terms of Use | Privacy Policy | Sitemap